We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Featured Industry Insights

Latest Industry Insights

A newborn baby in hospital with a nurse leaning over administering treatment in preparation for LNP-mediated gene therapy.
Industry Insight

Building the Next Generation of Genetic Medicines With LNPs

A recent milestone study used the LNP delivery system developed by Acuitas Therapeutics to treat a newborn with urea cycle disorder (UCD) successfully with a personalized CRISPR therapy. We spoke to Dr. Ying Tam, their CSO, to find out more.
Digital drug capsule with circuit patterns releasing glowing particles, symbolizing AI.
Industry Insight

AI and Synthetic Biology: Balancing Innovation With Biosecurity

AI is revolutionizing biotechnology innovation, but industry stakeholders must work together to mitigate its risks. In this article, Adam Clore explores the role of nucleic acid biosecurity screening tools and how they can be improved.
Group of human cells floating on a light green background.
Industry Insight

From Policy to Practice: How Human-Based In Vitro Models Are Reshaping Discovery

Discover how scalable, human-based in vitro models are reshaping discovery pipelines, balancing complexity with reproducibility, and enabling new kinds of experimentation that go beyond the limits of animal research.
Five male and female cell and gene therapy scientists with their arms crossed.
Industry Insight

From Bench to Boardroom: Leading Cell and Gene Therapy Through Uncertainty

In this opinion piece, Dr. Stella Vnook explores how cell and gene therapy leaders are adapting to today’s financial and regulatory headwinds, offering actionable insights into how biotech CEOs are rethinking capital strategy.
Female doctor discussing brain scan results with senior woman during Alzheimer's consultation.
Industry Insight

New Partnership Will Probe the Connection Between Tau Protein and Alzheimer’s

Technology Networks spoke with Nautilus Biotechnology and the Allen Institute about their new agreement to advance Alzheimer’s research through proteoform analysis.
A graphic of four pink balls, covered in cilia-like hair.
Industry Insight

Engineering Immune Responses: Protein Design for the Next Era of Cancer Therapy

Dr. Jamie Spangler gives a vision of how engineered proteins could overcome the toughest challenges in cancer immunotherapy.
Diverse group of people representing population-scale diversity for whole-genome sequencing studies.
Industry Insight

Whole-Genome Sequencing Enables Rare Variant Discovery at Scale

Illumina’s Rami Mehio discusses the whole-genome sequencing of 490,640 UK Biobank participants with Molly Coddington for Technology Networks.
A scientist holding up a vial containing a DNA double helix, representing cell and gene therapy manufacturing.
Industry Insight

FDA Delays Cell and Gene Therapy Approvals Following CMC Issues

Explore why cell and gene therapy manufacturing failures are now a leading cause of FDA rejections and how to avoid them.
A close up of a woman's eye, the target of a new stem cell therapy to treat blindness.
Industry Insight

A Stem Cell Therapy Resembling a Contact Lens Hopes To Cure Blindness

Stem cell therapy using iPSC technology on the surface of the eye could cure blindness by replacing damaged corneal cells – a new hope for vision restoration.
A blue drug pill on top of a black switchboard, representing AI-driven drug discovery.
Industry Insight

Beyond Black-Box Models: Advances in Data-Driven ADMET Modeling

Discover how AI-powered ADMET modeling can enable the prediction of toxicity and pharmacokinetics with depth, transparency and scientific rigor.
Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter